Odronextamab (Odro) plus chemotherapy ( plus CHOP) in patients (pts) with previously untreated diffuse large B- cell lymphoma (DLBCL): First results from Part 1 of the Phase 3 OLYMPIA-3 study
ONCOLOGY RESEARCH AND TREATMENT, cilt.49, ss.116, 2026 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Özet
- Cilt numarası: 49
- Basım Tarihi: 2026
- Dergi Adı: ONCOLOGY RESEARCH AND TREATMENT
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, MEDLINE, Academic Search Ultimate (EBSCO)
- Sayfa Sayıları: ss.116
- Gazi Üniversitesi Adresli: Evet